Analysis of DNA Methylation Status of the Promoter of Human Telomerase Reverse Transcriptase in Gastric Carcinogenesis

Background and Aims. Telomerase is expressed in normal somatic cells and reactivated in majority of tumor cells. Human telomerase reverse transcriptase (hTERT), a catalytic subunit of telomerase, is a rate-limiting factor of telomerase activity. Evidence has shown that gastric cancer is the result of genetics and epignomics. DNA methylation is one of the most important research fields in epigenomics. It is one of the mechanisms resulting in gene silencing in carcinogenesis. Methods. Genomic DNAs were extracted from normal gastric mucosa, precancerous lesions and gastric cancer samples and were modified by sodium bisulfite. The modified genomic DNAs were amplified by PCR with primers that did not contain CpG sites. Each PCR product was sequenced. By matching the sequencing results and the original sequence, the status of each sample was obtained. PCR was carried out to identify hTERT expression. Results. The promoter of hTERT in gastric cancer was more methylated than in the precancerous lesions and normal gastric mucosa (p < 0.05). hTERT was absent in normal gastric mucosa and its positive rate was higher in gastric cancer than in precancerous lesions (p < 0.05). Conclusions. hTERT promoter in gastric cancer was more methylated than in the precancerous lesions and normal gastric mucosa. This may suggest that the degree of methylation of the hTERT promoter was increased during gastric carcinogenesis and may be a potential biological maker in early diagnosis of gastric cancer. During gastric carcinogenesis, expression of hTERT was increased. This may suggest that methylation of hTERT may influence expression of hTERT. (C) 2010 IMSS. Published by Elsevier Inc.